These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22284243)

  • 1. The association of physical activity with novel adipokines in patients with type 2 diabetes.
    Kadoglou NP; Vrabas IS; Kapelouzou A; Angelopoulou N
    Eur J Intern Med; 2012 Mar; 23(2):137-42. PubMed ID: 22284243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
    Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
    Kadoglou NP; Iliadis F; Angelopoulou N; Sailer N; Fotiadis G; Voliotis K; Vitta I; Liapis CD; Alevizos M
    J Diabetes Complications; 2009; 23(3):160-6. PubMed ID: 18413173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Kadoglou NP; Vrabas IS; Sailer N; Kapelouzou A; Fotiadis G; Noussios G; Karayannacos PE; Angelopoulou N
    Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
    Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
    Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis.
    Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D
    Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
    Ezenwaka CE; Kalloo R
    Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
    Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
    Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels.
    Akbarzadeh S; Nabipour I; Assadi M; Movahed A; Jafari SM; Motamed N; Nazem H; Haraghy M; Pourbehi A; Bargahi A; Hajian N
    Cytokine; 2012 May; 58(2):295-9. PubMed ID: 22398372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.